Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-005921
Filing Date
2012-05-14
Accepted
2012-05-14 11:32:40
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2209381z10-q.htm 10-Q 473752
2 EX-31.1 a2209381zex-31_1.htm EX-31.1 7833
3 EX-31.2 a2209381zex-31_2.htm EX-31.2 7776
4 EX-32.1 a2209381zex-32_1.htm EX-32.1 4440
5 EX-32.2 a2209381zex-32_2.htm EX-32.2 4368
  Complete submission text file 0001047469-12-005921.txt   2028160

Data Files

Seq Description Document Type Size
6 EX-101.INS vstm-20120331.xml EX-101.INS 234148
7 EX-101.SCH vstm-20120331.xsd EX-101.SCH 12204
8 EX-101.CAL vstm-20120331_cal.xml EX-101.CAL 30782
9 EX-101.DEF vstm-20120331_def.xml EX-101.DEF 62573
10 EX-101.LAB vstm-20120331_lab.xml EX-101.LAB 187732
11 EX-101.PRE vstm-20120331_pre.xml EX-101.PRE 92539
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 12837186
SIC: 2834 Pharmaceutical Preparations